Predicting ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties plays an essential role in the drug design process because they account for approximately 60% of all drugs' failures in clinical studies. ComputaBio can accurately predict these properties using various computer models and massive pharmacological databases, thereby helping researchers eliminate molecules with poor ADMET properties and greatly reducing R&D costs.
Figure 1. ADMET Prediction.
|Project name||ADMET Prediction Service|
|Samples requirements||Our ADMET prediction service requires you to provide specific requirements.|
|Detection cycle||Decide according to your needs.|
|Service including||We provide you with raw data and analysis service.|
Scientists at ComputaBio are experienced using project data or published data to build QSAR and other models, predict ADMET properties of new compounds, and support multi-parameter optimization during the design process. We can also use the ADMET QSAR model established by the software vendor to estimate these attributes. Our ADMET prediction provides information about dose size and dose frequency, such as oral absorption, bioavailability, brain penetration, clearance (for exposure) and distribution (for frequency).
The main functions of ADMET prediction service:
|Absorption||Human Intestinal Absorption|
|Plasma Protein Binding|
|Metabolism||CYP450 1A2 Inhibitor|
|CYP450 1A2 Substrate|
|CYP450 2C9 Inhibitor|
|Toxicity||Acute Oral Toxicity|
ComputaBio' ADMET prediction service can significantly increase the hit rate of lead compounds and reduce the cost of later experimental screening. ADMET prediction service is a personalized and customized innovative scientific research service. Each project needs to be evaluated before the corresponding analysis plan and price can be determined. If you want to know more about service prices or technical details, please feel free to contact us.